An experimental blood test may one day detect the return of early stage breast cancer months before it is revealed by CT or MRI scans, researchers report. Tilak Sundaresan, clinical fellow in medicine at Brigham and Women’s Hospital, the Dana-Farber Cancer Institute and Massachusetts General Hospital, who co-authored a commentary published with the report, is quoted.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?